Mario Mandalà, Director of Medical Oncology at S.M. Misericordia Hospital and Associate Professor of Medical Oncology at the University of Perugia, shared a post on LinkedIn:
“Another independent academic effort signed by the EORTC – European Organisation for Research and Treatment of Cancer Melanoma Group.
The manuscript reports an updated European organization for research and treatment of cancer (EORTC) protocol for pathological evaluation of sentinel lymph nodes for merkel cell carcinoma (MCC).
Thanks to Anna Suzmera and Daniela Massi for leading this project
Delighted to be on board with Alexander Eggermont, Piotr Rutkowski, Bastian Schilling. Grateful to Università degli Studi di Perugia.”
Title: An updated European organization for research and treatment of cancer (EORTC) protocol for pathological evaluation of sentinel lymph nodes for merkel cell carcinoma (MCC)
Authors: Anna Szumera-Ciećkiewicz, Piotr Donizy, Thibault Kervarrec, Witold Skrzyński, Llucia Alos, Natalia Castrejon-De-Anta, Filippo Ugolini, Jakub Mizera, Daniela Mihic-Probst, Martin G. Cook, Bastian Schilling, Piotr Rutkowski, Alexander M.M. Eggermont, Mario Mandalà, Daniela Massi
Read the Full Article.
Other articles from EORTC on OncoDaily.